Please login to the form below

Not currently logged in


This page shows the latest Verzenio news and features for those working in and with pharma, biotech and healthcare.

Lilly surges on Verzenio survival data in early breast cancer

Lilly surges on Verzenio survival data in early breast cancer

New data with Eli Lilly’s CDK4/6 inhibitor Verzenio has sent the drug to the top of the class in patients with hormone receptor-positive, HER2-negative early-stage breast ... Meanwhile, Lilly also showed that Verzenio could have a benefit in the HER2+

Latest news

More from news
Approximately 8 fully matching, plus 8 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company
Jet Off with Maloff Protect

Latest intelligence

CHECKLIST 04: Let’s make your patient recruitment strategies a success
From how to generate insights to define your audience to drilling down those all-important key messages, our checklist has everything you need to think of, covered....
Multichannel engagement and the need for greater understanding of European markets
By Laurence Olding and Georgina James...
A snapshot of… Exscientia